EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 170 filers reported holding EAGLE PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 0.73 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $298,000 | -46.0% | 5,000 | -28.6% | 0.02% | -48.3% |
| Q2 2017 | $552,000 | -5.0% | 7,000 | 0.0% | 0.03% | -6.5% |
| Q1 2017 | $581,000 | +4.7% | 7,000 | 0.0% | 0.03% | 0.0% |
| Q4 2016 | $555,000 | +13.3% | 7,000 | 0.0% | 0.03% | +14.8% |
| Q3 2016 | $490,000 | +80.1% | 7,000 | 0.0% | 0.03% | +68.8% |
| Q2 2016 | $272,000 | -4.2% | 7,000 | 0.0% | 0.02% | 0.0% |
| Q1 2016 | $284,000 | -54.3% | 7,000 | 0.0% | 0.02% | -51.5% |
| Q4 2015 | $621,000 | +67.8% | 7,000 | +40.0% | 0.03% | +65.0% |
| Q3 2015 | $370,000 | +14.6% | 5,000 | +25.0% | 0.02% | +17.6% |
| Q2 2015 | $323,000 | – | 4,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Hudson Executive Capital LP | 1,323,794 | $79,534,000 | 3.54% |
| Park West Asset Management LLC | 1,171,880 | $70,406,000 | 2.96% |
| Matarin Capital Management, LLC | 170,008 | $10,214,000 | 0.98% |
| Smith, Graham & Co., Investment Advisors, LP | 140,014 | $8,412,000 | 0.82% |
| Capital Impact Advisors, LLC | 33,725 | $2,026,000 | 0.71% |
| U S GLOBAL INVESTORS INC | 18,800 | $1,130,000 | 0.51% |
| CHARTWELL INVESTMENT PARTNERS, LLC | 187,989 | $11,294,000 | 0.37% |
| Stanley-Laman Group, Ltd. | 24,000 | $1,442,000 | 0.34% |
| GLOBEFLEX CAPITAL L P | 18,751 | $1,127,000 | 0.21% |
| Foundry Partners, LLC | 70,357 | $4,227,000 | 0.16% |